Sign Up to like & get
recommendations!
0
Published in 2017 at "Biochemical and biophysical research communications"
DOI: 10.1016/j.bbrc.2017.01.146
Abstract: The current study focused on the role of Ku70, a DNA-dependent protein kinase (DNA-PK) complex protein, in pancreatic cancer cell resistance to gemcitabine. In both established cell lines (Mia-PaCa-2 and PANC-1) and primary human pancreatic…
read more here.
Keywords:
gemcitabine;
pancreatic cancer;
cancer cell;
gemcitabine induced ... See more keywords
Sign Up to like & get
recommendations!
0
Published in 2019 at "Journal of the American College of Cardiology"
DOI: 10.1016/s0735-1097(19)32793-7
Abstract: Gemcitabine is a pyrimidine antimetabolite that inhibits DNA synthesis and is used commonly as an adjuvant chemotherapy agent for resectable pancreatic cancer as a single agent. Gemcitabine is generally not considered as a cardiotoxic agent…
read more here.
Keywords:
agent;
gemcitabine;
gemcitabine induced;
cardiology ... See more keywords
Sign Up to like & get
recommendations!
0
Published in 2022 at "BMJ Case Reports"
DOI: 10.1136/bcr-2022-252083
Abstract: A woman in her 50s with HER2 (human epidermal growth factor receptor 2) positive, estrogen/progesterone receptor negative, metastatic invasive ductal carcinoma of the breast, presented with acral cyanosis and severe throbbing pain after recent administration…
read more here.
Keywords:
ischaemia patient;
gemcitabine induced;
breast;
induced digital ... See more keywords
Sign Up to like & get
recommendations!
0
Published in 2019 at "Current oncology"
DOI: 10.3747/co.26.5007
Abstract: Gemcitabine is a chemotherapeutic agent used in a wide variety of solid tumours. Known side effects include a dose-limiting myelosuppressive toxicity, mild rash, and radiation-dependent dermatitis. Rarely, localized inflammation in the form of pseudocellulitis has…
read more here.
Keywords:
gemcitabine;
case;
induced pseudocellulitis;
gemcitabine induced ... See more keywords